References
- HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J20062852353216611654
- National Heart, Lung, and Blood InstituteMorbidity and Mortality: Chart Book on Cardiovascular, Lung, and Blood DiseasesBethesda (MD)US Department of Health and Human Services, Public Health Service, National Institutes of Health2012 Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.htmAccessed March 17, 2014
- MathersCBoermaTFatDMThe Global Burden of Disease: 2004 UpdateGenevaWorld Health Organization2008
- MurphySLXuJQKochanekKDDeath: preliminary data for 2008Natl Vital Stat Rep201260151
- global initiative for chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseBethesda (MD)2013 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdfAccessed March 17, 2014
- GuarascioAJRaySMFinchCKSelfTHThe clinical and economic burden of chronic obstructive pulmonary disease in the USAClinicoecon Outcomes Res2013523524523818799
- American Thoracic Society/European Respiratory SocietyStandards for the Diagnosis and Management of Patients with COPD Version 1.2New YorkAmerican Thoracic Society2004 (updated 2005). Available from: http://www.thoracic.org/go/copdAccessed March 17, 2014
- O’ReillyJFWilliamsAEHoltKRiceLDefining COPD exacerbations: impact on estimation of incidence and burden in primary carePrim Care Respir J20061534635317064963
- JohnstonAKManninoDMEpidemiology of COPD exacerbationsWedzichaJAMartinezFJExacerbations of Chronic Obstructive Pulmonary DiseaseLondonInforma Healthcare20081526
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784785212324669
- SuissaSDell’anielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax20126795796322684094
- National Institute for Health and Care ExcellenceChronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update)2010 Available from: http://guidance.nice.org.uk/cg101Accessed March 17, 2014
- LindenauerPKPekowPSLahtiMCLeeYBenjaminEMRothbergMBAssociation of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary diseaseJAMA20103032359236720551406
- O’DonnellDEHernandezPKaplanACanadian thoracic society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary careCan Respir J200815Suppl A1A8A
- EvensenAManagement of COPD exacerbationsAm Fam Physician20108160761320187597
- DaviesLAngusRMCalverleyPMOral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet199935445646010465169
- ThompsonWHNielsonCPCalvalhoPCharanNBCrowleyJJControlled trial of oral prednisone in outpatients with acute COPD exacerbationAm J Respir Crit Care Med19961544074128756814
- Al-HabertSRogersHJPharmacokinetics of intravenous and oral prednisoloneBr J Clin Pharmacol1980105035087437263
- BeeralFJickHTylerJMA controlled study of the effect of prednisone on air-flow obstruction in severe pulmonary emphysemaN Engl J Med196326822623013970249
- CliftonMStuart-HarrisCHSteroid therapy in chronic bronchitisLancet196211311131313879957
- FranklinWMichelsonALLowellFCSchillerIWBronchodilators and corticosteroids in the treatment of obstructive pulmonary emphysemaN Engl J Med195825877477813541658
- KIeinRCSalbaggioJEKundurVGThe response of patients with “idiopathic” obstructive pulmonary disease and “allergic” obstructive bronchitis to prednisoneAnn Intern Med1969717117185360285
- MorganWKRuscheEA controlled trial of the effect of steroids in obstructive airway diseaseAnn Intern Med19646124825414204861
- MoyesENKershawRALong-continued treatment with tetracycline and prednisolone in chronic bronchitis: a controlled trialLancet195721187119113492604
- PettyTLBrinkGAMillerMWCorselloPRObjective functional improvement in chronic airway obstructionChest1970572162235415971
- AlbertRKMartinTRLewisSWControlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiencyAnn Intern Med1980927537586770731
- EmermanCLConnorsAFLukensTWMayMEEffronDA randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPDChest1989955635672920584
- BullardMJLiawSJTsaiYHMinHPEarly corticosteroid use in acute exacerbation of chronic airflow limitationAm J Emerg Med1996141391438924134
- MurataGHGorbyMSChickTWHalperinAKIntravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD: effect on patients with a history of multiple relapsesChest1990988458492209140
- NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med19993401941194710379017
- AaronSDVandemheenKLHevertPOutpatient oral prednisone after emergency treatment of chronic obstructive pulmonary diseaseN Engl J Med20033482618262512826636
- WaltersJAGibsonPGWood-BakerRHannaryMWaltersEHSystemic corticosteroids for acute exacerbation of chronic obstructive pulmonary diseaseCochrane Database Syst Rev20091CD00128819160195
- SayinerAAytemurZACiritMUnsalISystemic glucocorticoids in severe exacerbations of COPDChest200111972673011243949
- WaltersJAWantWMorleyCSoltaniAWood-BakerRDifferent durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD00689721975757
- LeuppiJDSchuetzPBingisserRShort-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJAMA20133092223223123695200
- CzockDKellerFRascheFMHäusslerUPharmacokinetics and pharmacodynamics of systemically administered glucocorticoidsClin Pharmacokinet200544619815634032
- HarrisonBDStokesTCHartGJVaughanDAAliNJRobinsonAANeed for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilator failureLancet198611811842868207
- JónssonSKjartanssonGGislaonDHelgasonHComparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophyllineChest1998947237263168567
- RattoDAlfaroCSipseyJGlovskyMMSharmaOPAre intravenous corticosteroids required in status asthmaticus?JAMA19882605275293385910
- de JongYPUilSMGrotjohanHPPostmaDSKerstjensHAvan den BergJWOral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind studyChest20071321741174717646228
- GunenHHacievliyagilSSYetkinOGulbasGMutluLCInEThe role of nebulised budesonide in the treatment of exacerbations of COPDEur Respir J20072966066717251232
- JohanssonSAAnderssonKEBrattsandRGruvstadEHednerPTopical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in manEur J Respir Dis Suppl198212274826958496
- BrogdenRNMcTavishDBudesonide: an updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitisDrugs1992443754071382936
- MaltaisFOstinelliJBorbeauJComparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease; a randomized controlled trialAm J Respir Crit Care Med200216569870311874817